Corient Private Wealth LP Takes Position in The Cooper Companies, Inc. $COO

Corient Private Wealth LP purchased a new stake in The Cooper Companies, Inc. (NASDAQ:COO) during the 2nd quarter, Holdings Channel reports. The firm purchased 22,370 shares of the medical device company’s stock, valued at approximately $1,604,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Avalon Trust Co acquired a new position in Cooper Companies during the second quarter valued at approximately $25,000. Root Financial Partners LLC raised its stake in shares of Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after purchasing an additional 162 shares in the last quarter. SJS Investment Consulting Inc. raised its stake in shares of Cooper Companies by 107.5% during the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after purchasing an additional 187 shares in the last quarter. Elevation Wealth Partners LLC boosted its holdings in shares of Cooper Companies by 1,136.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock valued at $29,000 after buying an additional 375 shares during the last quarter. Finally, J.Safra Asset Management Corp acquired a new stake in shares of Cooper Companies in the 2nd quarter valued at approximately $32,000. 24.39% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently commented on COO shares. JPMorgan Chase & Co. decreased their price objective on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research report on Friday, June 5th. UBS Group initiated coverage on shares of Cooper Companies in a research note on Tuesday, July 28th. They issued a “neutral” rating and a $75.00 target price for the company. Needham & Company LLC reduced their price target on Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a report on Friday, June 5th. Robert W. Baird lowered their price target on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a research report on Friday, June 5th. Finally, Weiss Ratings lowered Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $81.64.

Cooper Companies Trading Up 1.3%

COO stock opened at $70.64 on Friday. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83. The company has a market capitalization of $13.78 billion, a PE ratio of 59.86, a price-to-earnings-growth ratio of 1.82 and a beta of 0.82. The company’s 50-day simple moving average is $72.74 and its 200 day simple moving average is $70.46. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.96 earnings per share. As a group, sell-side analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.